Application 204922
- Type
- ANDA
- Sponsor
- AUROLIFE PHARMA LLC
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | OMEPRAZOLE AND SODIUM BICARBONATE | OMEPRAZOLE; SODIUM BICARBONATE | CAPSULE;ORAL | 20MG;1.1GM | No | No |
| 002 | OMEPRAZOLE AND SODIUM BICARBONATE | OMEPRAZOLE; SODIUM BICARBONATE | CAPSULE;ORAL | 40MG;1.1GM | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 13107-115 | Omeprazole and Sodium Bicarbonate | Omeprazole and Sodium Bicarbonate | Aurolife Pharma, LLC | ANDA | Current |
| 13107-115 | Omeprazole and Sodium Bicarbonate | Omeprazole and Sodium Bicarbonate | Aurolife Pharma, LLC | ANDA | Current |
| 13107-116 | Omeprazole and Sodium Bicarbonate | Omeprazole and Sodium Bicarbonate | Aurolife Pharma, LLC | ANDA | Current |
| 13107-116 | Omeprazole and Sodium Bicarbonate | Omeprazole and Sodium Bicarbonate | Aurolife Pharma, LLC | ANDA | Current |
| 69665-216 | Omeprazole and Sodium Bicarbonate | Omeprazole and Sodium Bicarbonate | Medarbor Llc | ANDA | Current |